This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NYSE Euronext Announces Trading Volumes For December 2013

NYSE Euronext today announced trading volumes for its global derivatives and cash equities exchanges for December 2013 1. Global derivatives average daily volume (“ADV”) of 5.9 million contracts, excluding Bclear in December 2013 decreased 7.6% compared to December 2012 and decreased 10.8% from November 2013. U.S. equity options volumes in December 2013 decreased 13.2% compared to December 2012 and decreased 9.9% sequentially. ADV in U.S. cash equities declined 8.7% year-over-year but increased 0.9% month-over-month. European cash equities ADV in December 2013 increased 13.6% compared to December 2012, but decreased 9.3% from November 2013 levels.

Highlights

  • NYSE Euronext global derivatives ADV in December 2013 of 5.9 million contracts, excluding Bclear decreased 7.6% from December 2012 and decreased 10.8% from November 2013 levels.
  • NYSE Euronext European derivatives products ADV in December 2013 of 2.4 million contracts, excluding Bclear, increased 1.5% compared to December 2012 but decreased 13.3% from November 2013 levels. Including Bclear, NYSE Liffe’s trade administration and clearing service for OTC products, European derivatives ADV decreased 11.3% compared to December 2012, and decreased 3.9% from November 2013. Total MSCI World Index yearly volumes were up 31% to 337,000 lots, with open interest of over 110,000 lots, up 245% from December 2012.
  • NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex Options) ADV of 3.4 million contracts in December 2013 decreased 13.2% compared to December 2012 levels and decreased 9.9% from November 2013 levels. NYSE Euronext’s U.S. options exchanges accounted for 24.5% of total U.S. consolidated equity options trading in December 2013, down from 27.2% in December 2012, and down from 26.0% in November 2013.
  • NYSE Liffe U.S. ADV of approximately 65,300 contracts decreased from 72,600 contracts in December 2012 but increased from 32,300 contracts in November 2013. 2013 ADV vs. 2012 ADV for MSCI futures is up 71%. OI for year end 2013 vs. year end 2012 is up 48%.
  • NYSE Euronext European cash products ADV of 1.2 million transactions in December 2013 increased 13.6% compared to December 2012, but decreased 9.3% compared to November 2013.
  • NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE MKT) handled ADV of 1.4 billion shares in December 2013 decreased 8.7% compared to December 2012 but increased 0.9% compared to November 2013. NYSE Euronext’s Tape A matched market share in December 2013 was 31.0%, down from 31.9% in December 2012, but up from 29.5% in November 2013.
  • The preliminary average net revenue per transaction type (as defined below) for each of the primary trading venues in the fourth quarter of 2013 is included below:
                 
Trading Venue       Q4 2013   Q3 2013   Q4 2012
European Derivatives (ex Bclear) 1       $0.664   $0.622   $0.673
 
U.S. Options 2 $0.170 $0.165 $0.144
 
U.S. Cash 3 $0.049 $0.049 $0.040
 
EU Cash 4       $0.610   $0.543   $0.583
 
   

1

 

Average net revenue per contract, excluding Bclear.

2

Average net revenue per contract.

3

Average net revenue per 100 shares handled.

4

Average net revenue per transaction.

 

Please click here for the Monthly Transaction Activity Data Table.

About IntercontinentalExchange Group, Inc.

IntercontinentalExchange (NYSE: ICE) is the leading network of regulated exchanges and clearing houses for financial and commodity markets. ICE delivers transparent, reliable and accessible data, technology and risk management services to markets around the world through its portfolio of exchanges, including the New York Stock Exchange, ICE Futures, Liffe and Euronext.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs